Literature DB >> 18196721

Abnormalities of serum electrolyte concentrations in dogs with hypoadrenocorticism.

Jennifer A Adler1, Kenneth J Drobatz, Rebecka S Hess.   

Abstract

BACKGROUND: The sensitivity and specificity of the sodium to potassium ratio (Na:K ratio) as a cutoff for recommendation of an adrenocorticotropic hormone (ACTH) stimulation test in dogs suspected of having hypoadrenocorticism (HA) is unknown. Additionally, abnormalities in plasma ionized calcium (iCa2+) and ionized magnesium (iMg2+) concentrations and venous pH of dogs with HA are incompletely documented.
OBJECTIVES: To define the sensitivity and specificity of the Na:K ratio as a diagnostic aid for HA in dogs and to examine for associations between venous pH and the Na:K ratio, iCa2+ concentration, or iMg2+ concentration in dogs with HA. ANIMALS: Seventy-six dogs with HA and 200 dogs randomly selected from the general hospital population.
METHODS: Retrospective study. Dogs were included in the study if results of an ACTH stimulation test confirmed a diagnosis of HA, the dog had a serum sodium concentration below the reference range or a serum potassium concentration above the reference range, and the dog was treated with mineralocorticoids. Receiver operating curve analysis was used to determine optimal cutoffs of sensitivity and specificity for the Na:K ratio in diagnosing HA.
RESULTS: Use of Na:K ratios of 27 or 28 classified 95% of dogs correctly as diseased or not diseased. The sensitivity of a Na:K ratio of 28 was 93% (CI, 85-98%) and that of 27 was 89% (CI, 80-95%). The specificity of a Na:K ratio of 28 was 96% (CI, 92-98%) and that of 27 was 97% (CI, 93- 99%). The sensitivity and specificity of a Na:K ratio of 24 were 79% (95% CI, 67-86%) and 100% (98%, CI, 97%-100%), respectively. CONCLUSIONS AND CLINICAL IMPORTANCE: Na:K ratios of 27 or 28 identify the highest percentage of dogs with suspected mineralocorticoid and glucocorticoid deficiency correctly. In dogs with a Na:K ratio of 24 or less, the likelihood of confirming a diagnosis of HA with an ACTH stimulation test is high.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18196721     DOI: 10.1892/06-270.1

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  11 in total

1.  A retrospective study of dogs with atypical hypoadrenocorticism: a diagnostic cut-off or continuum?

Authors:  J A Wakayama; E Furrow; L K Merkel; P J Armstrong
Journal:  J Small Anim Pract       Date:  2017-03-01       Impact factor: 1.522

2.  Clinical features of hypoadrenocorticism in soft-coated wheaten terrier dogs: 82 cases (1979-2013).

Authors:  Rebecca L Haviland; Rachel L Toaff-Rosenstein; Matthew P Reeves; Meryl P Littman
Journal:  Can Vet J       Date:  2016-04       Impact factor: 1.008

3.  Prevalence and clinical features of hypoadrenocorticism in Great Pyrenees dogs in a referred population: 11 cases.

Authors:  Magali Decôme; Marie-Claude Blais
Journal:  Can Vet J       Date:  2017-10       Impact factor: 1.008

4.  A Dog with Pseudo-Addison Disease Associated with Trichuris vulpis Infection.

Authors:  Luigi Venco; Valentina Valenti; Marco Genchi; Giulio Grandi
Journal:  J Parasitol Res       Date:  2011-06-08

5.  Serum Biochemical Phenotypes in the Domestic Dog.

Authors:  Yu-Mei Chang; Erin Hadox; Balazs Szladovits; Oliver A Garden
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

6.  Evaluation of Basal Serum or Plasma Cortisol Concentrations for the Diagnosis of Hypoadrenocorticism in Dogs.

Authors:  A J Gold; D K Langlois; K R Refsal
Journal:  J Vet Intern Med       Date:  2016-10-07       Impact factor: 3.333

7.  Low-dose ACTH stimulation testing in dogs suspected of hypoadrenocorticism.

Authors:  Annabel Botsford; Ellen N Behrend; Robert J Kemppainen; Philippe R Gaillard; Frank Oprandy; Hollie P Lee
Journal:  J Vet Intern Med       Date:  2018-09-19       Impact factor: 3.333

Review 8.  Management of hypoadrenocorticism (Addison's disease) in dogs.

Authors:  Patty Lathan; Ann L Thompson
Journal:  Vet Med (Auckl)       Date:  2018-02-09

9.  Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison's Disease).

Authors:  Alisdair M Boag; Michael R Christie; Kerry A McLaughlin; Harriet M Syme; Peter Graham; Brian Catchpole
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism.

Authors:  Hayley Farr; Beasley L Mason; Susan L Longhofer
Journal:  Vet Rec       Date:  2020-01-23       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.